Differential Expression of Long Non-coding RNA Cancer Susceptibility Candidate 2 and Imprinted Gene H19 in Extrahepatic Cholangiocarcinoma.
10.3881/j.issn.1000-503X.14039
- Author:
Jia-Xing WANG
1
;
Wen-Feng SHEN
2
;
Rui XIAO
3
;
Xue-Min FENG
4
;
Rui-Ting MA
4
;
Ze-Feng WANG
5
;
Jian-Jun REN
1
Author Information
1. Department of Hepatobiliary Surgery, Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China.
2. Department of Ultrasound, Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China.
3. Molecular Pathology Laboratory, Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China.
4. Key Laboratory of Surgery, Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China.
5. Department of Imaging Diagnosis,Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China.
- Publication Type:Journal Article
- Keywords:
H19;
cancer susceptibility candidate 2;
expression analysis;
extrahepatic cholangiocarcinoma;
long non-coding RNA
- MeSH:
Bile Duct Neoplasms/genetics*;
Bile Ducts, Intrahepatic/metabolism*;
Cholangiocarcinoma/genetics*;
Gene Expression Regulation, Neoplastic;
Humans;
RNA, Long Noncoding/genetics*;
Tumor Suppressor Proteins/genetics*
- From:
Acta Academiae Medicinae Sinicae
2022;44(1):72-80
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression and the potential roles of long non-coding RNA(lncRNA)cancer susceptibility candidate 2(CASC2)and imprinted gene H19 in extrahepatic cholangiocarcinoma(ECC). Methods Four samples from patients with ECC were collected for high-throughput sequencing which was conducted to reveal the transcriptomic profiles of lncRNA CASC2 and H19.Bioinformatics tools were employed to predict the potential roles of the two genes.Another 22 ECC tissue samples and the cholangiocarcinoma cell lines(RBE,QBC939,HuH-28,and HuCCT1)with different degrees of differentiation were selected for validation.The para-carcinoma tissue and normal human intrahepatic biliary epithelial cell(HIBEC)were used as the control groups.The expression levels of lncRNA CASC2 and H19 in carcinoma tissue,para-carcinoma tissue,and cell lines were determined by real-time quantitative polymerase chain reaction(qRT-PCR).The correlation analysis was carried out for the clinical indicators of patients with the expression levels of the target genes. Results The two target genes showed significantly different expression between carcinoma tissue and para-carcinoma tissue(all P<0.05).Specifically,CASC2 had higher expression level in the carcinoma tissue than in the para-carcinoma tissue(t=1.262,P=0.025),whereas the expression of H19 showed an opposite trend(t=1.285,P=0.005).The expression levels of CASC2 in QBC939(t=8.114,P=0.015)and HuH-28(t=9.202,P=0.012)cells were significantly higher than that in the control group.The expression levels of H19 were significantly lower in RBE(t=-10.244,P<0.001),QBC939(t=-10.476,P<0.001),HuH-28(t=-19.798,P<0.001),and HuCCT1(t=-16.193,P=0.004)cells than in the control group.Bioinformatics analysis showed that CASC2 was mainly involved in the metabolic process and H19 in the development of multicellular organisms.Both CASC2 and H19 were related to catalytic activity.The expression level of lncRNA CASC2 was correlated with pathological differentiation(χ 2=6.222,P=0.022)and lymph node metastasis(χ2=5.455,P=0.020),and that of lncRNA H19 with pathological differentiation(χ2=1.174,P=0.029)and tumor size(χ2=-0.507,P=0.037). Conclusions In the case of ECC,lncRNA CASC2 and H19 have transcription disorders.lncRNA CASC2 is generally up-regulated in the carcinoma tissue,while H19 is down-regulated.Both genes have the potential to become new molecular markers for ECC.
